Head-to-head · free

Vail Resorts, Inc. vs The Precision Peptide Company

MTN vs PNGAF — return on capital, cash generation, margins and balance sheet side by side.

MTN

0 / 0

measures where MTN leads

PNGAF

0 / 0

measures where PNGAF leads

A simple count of which company scores better on each measure — not a recommendation to buy or sell.

MeasureMTN · FY2026PNGAF
Revenue$2.8B—
Net income$147.5M—
Revenue growth (yearly, multi-year)3.0%—
Free cash flow——
Free cash flow margin——
Net cash / (debt)——
ROIC7.7%—
Return on equity44.4%—
Gross margin41.3%—
Operating margin15.3%—
Net debt / EBITDA4.07x—

Figures are as reported by each company; latest fiscal year shown.

Where Vail Resorts, Inc.'s cash went (FY2026)

Capital spending
—
Buybacks
—
Dividends
—
Acquisitions
—
Net debt issued / (repaid)
—
Full MTN profile →

Where The Precision Peptide Company's cash went

Not reported yet.

Full PNGAF profile →

Ask which business is stronger

"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.

Compare them free

More comparisons